AB680, a selective CD73 inhibitor, induced the proliferation and cytotoxic activity of depleted CD8+ T cells and significantly inhibited the growth of colon cancer established by CT26 cells; moreover, it exhibited favorable pharmacokinetic properties. This evidence concerns the gene CD8A and colonic neoplasm.